Kstation

REGENOVUE (FINE / DEEP / SUB-Q) (1mL × 1 Syringe)

$42.00

Option

Formulation

Key ingredients

  • 01 Hyaluronic Acid24 mg/mLVolume & contour · 100% crosslinked BDDE monophasic, ultra-low endotoxin; graded Fine/Deep/Sub-Q; lidocaine-free

Product Line Overview
NeoGenesis Co., Ltd. HA Dermal Filler

REGENOVUE Series

FINE / Deep / Sub-Q

100% Cross-Linked Hyaluronic Acid Dermal Fillers (Without Lidocaine)

Common Features Across All Versions

The Regenovue series features a monophasic structure manufactured with advanced BDDE cross-linking technology. It offers high viscoelasticity and cohesiveness for smooth, uniform injection. This specific line maintains an exceptionally low endotoxin level (<0.0015 IU/mg) to minimize the risk of inflammation and adverse reactions.

Why KSTATION
✅
100% Authentic
Genuine Korean supply
🛃
97% Clearance
Proven customs success rate
❄️
Cold-Chain
Temperature-controlled shipping
Quick Version Comparison
Feature Regenovue FINE Regenovue Deep Regenovue Sub-Q
Formulation Type Low Viscosity Gel (Soft) Medium Viscosity Gel (Medium) High Viscosity Gel (Hard)
HA Concentration 24mg/ml HA (No Lidocaine) 24mg/ml HA (No Lidocaine) 24mg/ml HA (No Lidocaine)
Target Depth Superficial Dermis Mid to Deep Dermis Deep Dermis / Subcutaneous

Product Identification

Regenovue FINE

Low Viscosity Gel

Total Volume/Content
1.0ml × 1 Syringe (Per Box)
Core Ingredients & Technical Details
Primary Active Ingredients
Cross-linked Hyaluronic Acid 24mg/ml
Mechanism of Action

Injected into the superficial layers of the dermis to fill fine tissue depressions and physically smooth the skin surface.

100% Cross-linked HA (BDDE) Smooth Monophasic Structure Fine Particle Size
Efficacy Summary & Expected Benefits
Main Effects and Benefits

Correction of fine lines and superficial wrinkles, skin texture refinement, and delicate volume restoration.

Recommended/Targeted Areas of Use

Crow's feet (periorbital lines), perioral lines, glabellar lines, and shallow forehead lines.

Usage Protocol & Application Guide
Recommended Application Method
Injection into the Superficial Dermis.
Onset and Duration of Effect
Approximately 8 to 12 months.
Preparation Instructions

Supplied as a sterile, pre-filled syringe. Typically administered using a 30G needle.

Storage & Handling Instructions
Required Storage Temperature
2°C ~ 25°C (Do not freeze, protect from direct sunlight)
Shelf Life
24 months from the date of manufacture.
Precautions & Safety Notes
Contraindications Patients with a history of hypersensitivity to HA, pregnant or breastfeeding women, and those with severe inflammatory skin conditions.
Safety Warnings Over-injection in very thin skin may cause the Tyndall effect (a bluish tint). Intravascular injection is strictly prohibited.
Common Temporary Side Effects
  • Temporary erythema
  • Swelling and bruising
  • Mild pain at the injection site

Product Identification

Regenovue Deep

Medium Viscosity Gel

Total Volume/Content
1.0ml × 1 Syringe (Per Box)
Core Ingredients & Technical Details
Primary Active Ingredients
Cross-linked Hyaluronic Acid 24mg/ml
Mechanism of Action

Injected into the mid-to-deep dermis to elevate deeper skin depressions and restore lost volume. Features a balanced structure combining softness and elasticity with a dense cross-linking matrix.

100% Cross-linked HA (BDDE) Medium Particle Size Excellent Shape Retention
Efficacy Summary & Expected Benefits
Main Effects and Benefits

Correction of moderate to deep wrinkles, lip augmentation, and natural volume enhancement of facial contours.

Recommended/Targeted Areas of Use

Nasolabial folds, marionette lines, deep forehead wrinkles, lips, and cheeks.

Usage Protocol & Application Guide
Recommended Application Method
Injection into the Mid to Deep Dermis.
Onset and Duration of Effect
Approximately 8 to 12 months.
Preparation Instructions

Supplied as a sterile, pre-filled syringe. Typically administered using a 27G needle.

Storage & Handling Instructions
Required Storage Temperature
2°C ~ 25°C (Store at room temperature)
Shelf Life
24 months from the date of manufacture.
Precautions & Safety Notes
Contraindications Patients with HA allergies or active infections/inflammation at the proposed injection site.
Safety Warnings Must be injected at the correct depth; superficial injection of a medium-particle filler may result in visible or palpable lumps.
Common Temporary Side Effects
  • Temporary swelling and bruising
  • Tenderness and redness at the injection site

Product Identification

Regenovue Sub-Q

High Viscosity Gel

Total Volume/Content
1.0ml × 1 Syringe (Per Box)
Core Ingredients & Technical Details
Primary Active Ingredients
Cross-linked Hyaluronic Acid 24mg/ml
Mechanism of Action

Forms a sturdy support structure in the deep dermis or subcutaneous layer to induce distinct three-dimensional projection and structural lifting. Possesses the highest degree of cross-linking and viscoelasticity in the series.

100% Cross-linked HA (BDDE) Large Particle Size Strong Resistance to Pressure
Efficacy Summary & Expected Benefits
Main Effects and Benefits

Facial contouring, restoration of severe volume deficits, structural shaping, and correction of very deep folds.

Recommended/Targeted Areas of Use

Chin, nose bridge, jawline, cheekbones, and severe nasolabial folds.

Usage Protocol & Application Guide
Recommended Application Method
Injection into the Deep Dermis, Subcutaneous layer, or Supraperiosteal plane.
Onset and Duration of Effect
Approximately 8 to 12 months (varies depending on individual metabolism and injection site).
Preparation Instructions

Due to the high viscosity and large particle size, an appropriately sized needle or cannula (typically 25G or 27G) should be used.

Storage & Handling Instructions
Required Storage Temperature
2°C ~ 25°C
Shelf Life
24 months from the date of manufacture.
Precautions & Safety Notes
Contraindications Patients with bleeding disorders, a tendency to form keloids, or a history of severe allergies.
Safety Warnings Strict aspiration is required to prevent vascular occlusion, tissue necrosis, or blindness, particularly in high-risk areas with complex vasculature like the nose and glabella.
Common Temporary Side Effects
  • Firmness at the injection site
  • Prolonged swelling and bruising
  • Localized tenderness
Keywords & Search Terms
Regenovue NeoGenesis HA Filler Non-Lidocaine Fine wrinkle filler Nasolabial fold filler Contour filler High cohesive filler
Frequently Asked Questions
What is REGENOVUE used for?

The REGENOVUE series is used to correct wrinkles, refine skin texture, and restore facial volume. FINE corrects fine lines and superficial wrinkles (crow's feet, perioral lines, glabellar lines); Deep corrects moderate to deep wrinkles (nasolabial folds, marionette lines) and augments lips; and Sub-Q provides facial contouring and structural shaping of the chin, nose bridge, jawline, and cheekbones.

What is REGENOVUE made of?

Every version contains 100% cross-linked Hyaluronic Acid at 24mg/ml, without lidocaine. It features a monophasic structure manufactured with advanced BDDE cross-linking technology and maintains an exceptionally low endotoxin level (less than 0.0015 IU/mg).

How long do results from REGENOVUE last?

Results from all three versions (FINE, Deep, Sub-Q) typically last approximately 8 to 12 months, varying depending on individual metabolism and injection site.

Who should administer REGENOVUE?

REGENOVUE is a professional injectable administered into the appropriate skin layer (superficial dermis, mid to deep dermis, or subcutaneous/supraperiosteal) depending on the version. Intravascular injection is strictly prohibited, and strict aspiration is required in high-risk areas like the nose and glabella. It is contraindicated in patients with HA hypersensitivity, pregnant or breastfeeding women, severe inflammatory skin conditions, bleeding disorders, or a keloid tendency.

Who manufactures REGENOVUE?

REGENOVUE is manufactured by NeoGenesis Co., Ltd.

Authentic Regenovue FINE Deep Sub-Q Hyaluronic Acid Dermal Filler Korea Wholesale

REGENOVUE (FINE / DEEP / SUB-Q) (1mL × 1 Syringe)

$42.00

$42.00

Further reading